CHMFL-26 is a highly potent irreversible HER2 inhibitor for use in the treatment of HER2-positive and HER2-mutant cancers.
Cao JY, Qi S, Wu H, Wang AL, Liu QW, Li XX, Wang BL, Ge J, Zou FM, Chen C, Wang JJ, Hu C, Liu J, Wang WC, Liu QS.
Cao JY, et al. Among authors: liu j, liu qs, liu qw.
Acta Pharmacol Sin. 2022 Oct;43(10):2678-2686. doi: 10.1038/s41401-022-00882-x. Epub 2022 Feb 28.
Acta Pharmacol Sin. 2022.
PMID: 35228653
Free PMC article.